NPI: 1215281712 · BANGOR, ME 04401 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/05/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/05/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43,780 | $689K |
| 2019 | 55,731 | $703K |
| 2020 | 34,415 | $591K |
| 2021 | 29,062 | $614K |
| 2022 | 23,130 | $610K |
| 2023 | 10,925 | $492K |
| 2024 | 7,052 | $343K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 85,352 | 4,382 | $3.80M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 61,691 | 2,648 | $177K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 696 | 353 | $32K |
| J1756 | Injection, iron sucrose, 1 mg | 12,383 | 2,345 | $30K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 75 | 36 | $16.62 |
| 82728 | 2,343 | 1,502 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,956 | 1,255 | $0.00 |
| 83550 | 2,287 | 1,438 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,849 | 993 | $0.00 |
| A4657 | Syringe, with or without needle, each | 3,872 | 2,572 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 146 | 91 | $0.00 |
| 90674 | 76 | 52 | $0.00 | |
| 87340 | 16 | 13 | $0.00 | |
| 82746 | 18 | 17 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 19 | 18 | $0.00 |
| 85048 | 3,447 | 2,294 | $0.00 | |
| 83970 | 2,974 | 1,984 | $0.00 | |
| 83540 | 2,420 | 1,547 | $0.00 | |
| 85041 | 3,458 | 2,300 | $0.00 | |
| 82108 | 17 | 16 | $0.00 |